Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14038)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 27, 2014 (publication date) through Nov 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Enguita-Germán M, Fortes P. Targeting the insulin-like growth factor pathway in hepatocellular carcinoma. World J Hepatol 2014; 6(10): 716-737 [PMID: 25349643 DOI: 10.4254/wjh.v6.i10.716] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i10/716.htm |
| Number | Citing Articles |
| 1 |
Enas Mahmoud Moustafa, Laila Ahmed Rashed, Mohammed M. El-Sebaie, Noura Magdy Thabet, Mohamed Khairy Abdel-Rafei. Crosstalk between ER-stress and apoptosis in irradiated HepG2 cells with gemcitabine: implication of PI3K/AKT and IκB/NF-κB signaling pathways. Journal of Radiation Research and Applied Sciences 2020; 13(1): 144 doi: 10.1080/16878507.2020.1715569
|
| 2 |
Masafumi Ono, Koji Fujita, Kiyoyuki Kobayashi, Tsutomu Masaki. Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma. Hepatology Research 2023; 53(7): 579 doi: 10.1111/hepr.13912
|
| 3 |
Astrid A. Glück, Daniel M. Aebersold, Yitzhak Zimmer, Michaela Medová. Interplay between receptor tyrosine kinases and hypoxia signaling in cancer. The International Journal of Biochemistry & Cell Biology 2015; 62: 101 doi: 10.1016/j.biocel.2015.02.018
|
| 4 |
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy. Materials Today 2019; 25: 66 doi: 10.1016/j.mattod.2018.10.040
|
| 5 |
Sun-Min Lee, Jeongsil Kim-Ha, Won-Young Choi, Jungwoo Lee, Dawon Kim, Jinyoung Lee, Eunji Choi, Young-Joon Kim. Interplay of Genetic and Epigenetic Alterations in Hepatocellular Carcinoma. Epigenomics 2016; 8(7): 993 doi: 10.2217/epi-2016-0027
|
| 6 |
Lizhi Xiao, Enhua Xiao. Blood oxygen level–dependent functional magnetic resonance imaging can evaluate the efficiency of transcatheter arterial chemoembolization in hepatocellular carcinoma. Journal of Interventional Medicine 2019; 2(1): 5 doi: 10.1016/j.jimed.2019.05.002
|
| 7 |
Jameel Al-Tamimi, Abdelhabib Semlali, Iftekhar Hassan, Hossam Ebaid, Ibrahim M. Alhazza, Syed H. Mehdi, Mohammed Al-Khalifa, Mohammad S. Alanazi. Samsum Ant Venom Exerts Anticancer Activity Through ImmunomodulationIn VitroandIn Vivo. Cancer Biotherapy and Radiopharmaceuticals 2018; 33(2): 65 doi: 10.1089/cbr.2017.2400
|
| 8 |
Melchiorre Cervello, Giuseppa Augello, Antonella Cusimano, Maria Rita Emma, Daniele Balasus, Antonina Azzolina, James A. McCubrey, Giuseppe Montalto. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma. Advances in Biological Regulation 2017; 65: 59 doi: 10.1016/j.jbior.2017.06.002
|
| 9 |
Li Chen, Yundong Wei, Shimei Zhao, Mengliang Zhang, Xiaoting Yan, Xiangyun Gao, Jinxia Li, Yutong Gao, Anwen Zhang, Ying Gao. Antitumor and immunomodulatory activities of total flavonoids extract from persimmon leaves in H22 liver tumor-bearing mice. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28440-8
|
| 10 |
Go J. Yoshida, Arata Azuma, Yukiko Miura, Akira Orimo. Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies. International Journal of Molecular Sciences 2019; 20(9): 2256 doi: 10.3390/ijms20092256
|
| 11 |
Pasquale Agosti, Carlo Sabbà, Antonio Mazzocca. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(2): 607 doi: 10.1016/j.bbadis.2017.11.026
|
| 12 |
Fang Wang, Thomas Bank, Gregory Malnassy, Maribel Arteaga, Na Shang, Annika Dalheim, Xianzhong Ding, Scott J. Cotler, Mitchell F. Denning, Michael I. Nishimura, Peter Breslin, Wei Qiu. Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival. Hepatology Communications 2018; 2(6): 732 doi: 10.1002/hep4.1181
|
| 13 |
Ala’a Al Hrout, Karla Cervantes-Gracia, Richard Chahwan, Amr Amin. Modelling liver cancer microenvironment using a novel 3D culture system. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-11641-7
|
| 14 |
Hyuk Moon, Simon Weonsang Ro. MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma. Cancers 2021; 13(12): 3026 doi: 10.3390/cancers13123026
|
| 15 |
Luciano Sobrevals, Mónica Enguita, Jorge Quiroga, Jesús Prieto, Puri Fortes, Joseph Charles Glorioso. Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats. PLOS ONE 2016; 11(9): e0162955 doi: 10.1371/journal.pone.0162955
|
| 16 |
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Qiang Chen, Chu-Xia Deng. Sirt6 ablation in the liver causes fatty liver that increases cancer risk by upregulating Serpina12. EMBO Reports 2024; 25(3): 1361 doi: 10.1038/s44319-024-00071-3
|
| 17 |
Winston T. Stauffer, Michael Bobardt, Daren R. Ure, Robert T. Foster, Philippe Gallay, Vadim Ten. Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH. PLOS ONE 2024; 19(4): e0301711 doi: 10.1371/journal.pone.0301711
|
| 18 |
Maria Roméria da Silva, Gabriela Alves Moreira, Ronni Anderson Gonçalves da Silva, Éverton de Almeida Alves Barbosa, Raoni Pais Siqueira, Róbson Ricardo Teixera, Márcia Rogéria Almeida, Abelardo Silva Júnior, Juliana Lopes Rangel Fietto, Gustavo Costa Bressan. Splicing Regulators and Their Roles in Cancer Biology and Therapy. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/150514
|
| 19 |
Marie Boyle, Jelena Mann. WITHDRAWN: Epigenetics in Chronic Liver Disease. Journal of Hepatology 2017; doi: 10.1016/j.jhep.2017.08.016
|
| 20 |
Hong Li, Xiumei Jiang, Shengjie Zhu, Lihong Sui. Identification of personalized dysregulated pathways in hepatocellular carcinoma. Pathology - Research and Practice 2017; 213(4): 327 doi: 10.1016/j.prp.2017.01.015
|
| 21 |
Inga Hochnadel, Uta Kossatz-Boehlert, Nils Jedicke, Henrike Lenzen, Michael P. Manns, Tetyana Yevsa. Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers. Human Vaccines & Immunotherapeutics 2017; 13(12): 2931 doi: 10.1080/21645515.2017.1359362
|
| 22 |
Enakshi Sivasudhan, Neil Blake, Zhi-Liang Lu, Jia Meng, Rong Rong. Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.642443
|
| 23 |
Jianghong Cheng, Yanhong Zhong, Shuai Chen, Yan Sun, Lantang Huang, Yujia Kang, Baozhen Chen, Gang Chen, Fengli Wang, Yingpu Tian, Wenjie Liu, Gen‐Sheng Feng, Zhongxian Lu. Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways. The FASEB Journal 2017; 31(12): 5530 doi: 10.1096/fj.201700120RR
|
| 24 |
David Prince, Ken Liu, Weiqi Xu, Minjiang Chen, Jin-Yu Sun, Xiao-Jie Lu, Jiansong Ji. Management of patients with intermediate stage hepatocellular carcinoma. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920970840
|
| 25 |
Fabio Nascimbeni, Judith Aron-Wisnewsky, Raluca Pais, Joan Tordjman, Christine Poitou, Frederic Charlotte, Pierre Bedossa, Thierry Poynard, Karine Clément, Vlad Ratziu. Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease. BMJ Open Gastroenterology 2016; 3(1): e000075 doi: 10.1136/bmjgast-2015-000075
|
| 26 |
Letiția Adela Maria Streba, Cristin Constantin Vere, Ion Rogoveanu, Costin Teodor Streba. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question. World Journal of Gastroenterology 2015; 21(14): 4103-4110 doi: 10.3748/wjg.v21.i14.4103
|
| 27 |
Md Gulam Musawwir Khan, Amit Ghosh, Bhavesh Variya, Madanraj Appiya Santharam, Awais Ullah Ihsan, Sheela Ramanathan, Subburaj Ilangumaran. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07285-3
|
| 28 |
Masahito Shimizu, Yohei Shirakami, Hiroyasu Sakai, Masaya Kubota, Takahiro Kochi, Takayasu Ideta, Tsuneyuki Miyazaki, Hisataka Moriwaki. Chemopreventive Potential of Green Tea Catechins in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2015; 16(3): 6124 doi: 10.3390/ijms16036124
|
| 29 |
Chuan Chen, Ge Wang. Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy. World Journal of Hepatology 2015; 7(15): 1964-1970 doi: 10.4254/wjh.v7.i15.1964
|
| 30 |
Jean-Charles Nault. Reports from the International Liver Cancer Association (ILCA) congress 2014. Journal of Hepatology 2015; 62(2): 477 doi: 10.1016/j.jhep.2014.11.015
|
| 31 |
Vladimir M. Subbotin. Privileged portal metastasis of hepatocellular carcinoma in light of co-evolution of a visceral portal system and the liver in the chordate lineage: a search for therapeutic targets. Drug Discovery Today 2018; 23(3): 548 doi: 10.1016/j.drudis.2018.01.020
|
| 32 |
Zheng Lou, Yong‑Qiang Gong, Xing Zhou, Guo‑Huang Hu. Low expression of miR‑199 in hepatocellular carcinoma contributes to tumor cell hyper‑proliferation by negatively suppressing XBP1. Oncology Letters 2018; doi: 10.3892/ol.2018.9476
|
| 33 |
Linlin Jiang, Qin Meng, Lixiu Liu, Weihang Li. A Comprehensive Review on Molecular Mechanisms, Treatments, and Brief Role of Natural Products in Hepatocellular Cancer. Natural Product Communications 2024; 19(9) doi: 10.1177/1934578X241284873
|
| 34 |
Xuefeng Wang, Liangyu Lin, Bin Lan, Yu Wang, Liming Du, Xiaodong Chen, Qing Li, Keli Liu, Mingyuan Hu, Yueqing Xue, Arthur I. Roberts, Changshun Shao, Gerry Melino, Yufang Shi, Ying Wang. IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages. Science Advances 2020; 6(48) doi: 10.1126/sciadv.abb7389
|
| 35 |
J.M. Redman, E.M. Hill, D. AlDeghaither, L.M. Weiner. Mechanisms of action of therapeutic antibodies for cancer. Molecular Immunology 2015; 67(2): 28 doi: 10.1016/j.molimm.2015.04.002
|
| 36 |
Maysa A. Mobasher, Mousa O. Germoush, Hala Galal El-Tantawi, Karim Samy El-Said. Metformin Improves Biochemical and Pathophysiological Changes in Hepatocellular Carcinoma with Pre-Existed Diabetes Mellitus Rats. Pathogens 2021; 10(1): 59 doi: 10.3390/pathogens10010059
|
| 37 |
Hamid Ceylan. Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis. Medical Oncology 2021; 38(6) doi: 10.1007/s12032-021-01510-0
|
| 38 |
Hongyan Liu, Hong Xu, Chenghong Zhang, Meng Gao, Xiaoguang Gao, Chuchu Ma, Li Lv, Dongyan Gao, Sa Deng, Changyuan Wang, Yan Tian. Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer. Pharmaceutical Research 2016; 33(11): 2828 doi: 10.1007/s11095-016-2010-5
|
| 39 |
A.P. Alves, A.C. Mamede, M.G. Alves, P.F. Oliveira, S.M. Rocha, M.F. Botelho, C.J. Maia. Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?. Current Cancer Drug Targets 2018; 19(1): 26 doi: 10.2174/1568009618666180430144441
|
| 40 |
Yachao Tao, Menglan Wang, Enqiang Chen, Hong Tang. Liver Regeneration: Analysis of the Main Relevant Signaling Molecules. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/4256352
|
| 41 |
Manar Salah El-Din, AlShaimaa Mohamed Taha, Ahmed Abdel-Aziz Sayed, Ahmed Mohamed Salem. Ziziphus spina-christi leaves methanolic extract alleviates diethylnitrosamine-induced hepatocellular carcinoma in rats. Biochemistry and Cell Biology 2019; 97(4): 437 doi: 10.1139/bcb-2018-0318
|
| 42 |
Catia Lippolis, Maria Grazia Refolo, Rosalba D’Alessandro, Nicola Carella, Caterina Messa, Aldo Cavallini, Brian Irving Carr. Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0210-1
|
| 43 |
Xiaowei Chi, Liejun Jiang, Yulin Yuan, Xinyan Huang, Xuemei Yang, Steven Hochwald, Jie Liu, Huayi Huang. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02279-w
|
| 44 |
Shuping Zhou, Yongfang Ma, Xueke Liu, Pan Yu, Ning Huang, Li Song, Ruyue Xu, Zhen Huo, Tao Zhu, Xiaolong Tang. Targeted Delivery of Glypican 3 (GPC3) Antibody-Modified MicroRNA (miR let-7b-5p) Polymer Nanoparticles to Sorafenib-Resistant Hepatsocellular Carcinoma Cells. Journal of Biomedical Nanotechnology 2021; 17(4): 677 doi: 10.1166/jbn.2021.3033
|
| 45 |
Chuanzong Zhao, Qian Wang, Ben Wang, Qi Sun, Zhaobin He, Jianguo Hong, Florian Kuehn, Enyu Liu, Zongli Zhang. IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma. Oncotarget 2017; 8(67): 111922 doi: 10.18632/oncotarget.22952
|
| 46 |
Vladimir M. Subbotin. A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?. Medical Hypotheses 2019; 126: 109 doi: 10.1016/j.mehy.2019.03.019
|
| 47 |
Koji Fujita, Hisakazu Iwama, Hisaaki Miyoshi, Joji Tani, Kyoko Oura, Tomoko Tadokoro, Teppei Sakamoto, Takako Nomura, Asahiro Morishita, Hirohito Yoneyama, Tsutomu Masaki. Diabetes mellitus and metformin in hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(27): 6100-6113 doi: 10.3748/wjg.v22.i27.6100
|
| 48 |
Mustafa A. Barbhuiya, Adam C. Mirando, Brian W. Simons, Ghali Lemtiri-Chlieh, Jordan J. Green, Aleksander S. Popel, Niranjan B. Pandey, Phuoc T. Tran. Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma. Oncotarget 2017; 8(60): 101520 doi: 10.18632/oncotarget.21148
|
| 49 |
Tanzeel Yousaf, Yuting Sun, Wajeeha Naz, Yang Liu, Jiaqi Xu, Sen Yuan, Kangwei Wu, Min Wang, Jun Wang, Mingxiong Guo, Guihong Sun. Multiomics Analysis of Endocytosis upon HBV Infection and Identification of SCAMP1 as a Novel Host Restriction Factor against HBV Replication. International Journal of Molecular Sciences 2022; 23(4): 2211 doi: 10.3390/ijms23042211
|
| 50 |
Bryan Fleming, Mitchell Ho. Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer. Toxins 2016; 8(10): 274 doi: 10.3390/toxins8100274
|